Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Acta Neurologica Scandinavica. Supplementum|January 1, 1997
Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patientsH B Rasmussen, C Geny, L Deforges, et al.
Acta Neurologica Scandinavica|February 1, 1976
Lysolecithin fusion of cells from multiple sclerosis patients with Vero cellsT Ammitzboll, H Offner, J Clausen, et al.
Ecological Applications : a Publication of the Ecological Society of America|March 28, 2022
Does large dam removal restore downstream riparian vegetation diversity? Testing predictions on the Elwha River, Washington, USARebecca L Brown, Cody C Thomas, Erin S Cubley, et al.
Bone Marrow Transplantation|February 16, 2000
Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storageA L Petzer, E Gunsilius, N Zech, et al.
Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantationJ Clausen, A L Petzer, B Vergeiner, et al.
Chest|March 1, 1997
Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep qualityJ E Dimsdale, T Coy, S Ancoli-Israel, et al.
Ugeskrift for Laeger|January 2, 1989
[Effect of posture on the diuretic treatment of decompensated cirrhosis and heart failure]C Wilken-Jensen, H Ring-Larsen, J H Henriksen, et al.
Biochemistry|March 21, 2015
Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8Christophe Decroos, Dane J Clausen, Brandon E Haines, et al.
Bone Marrow Transplantation|September 28, 2011
Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptorsJ Clausen, B Kircher, J Auberger, et al.
Clinical and Experimental Immunology|May 12, 2007
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantationJ Clausen, D Wolf, A L Petzer, et al.
Pageof 21